This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Problematic mergers may require prohibition, not complex remedies, CMA's Coscelli says

By Victoria Ibitoye and Natalie McNelis ( October 2, 2020, 16:01 GMT | Insight) -- Merging companies that propose complicated remedy packages — such as those proposed in the Google-Fitbit deal — are unlikely to win over the UK’s competition regulator, which is increasingly of the view that prohibition is the only answer where deals give rise to significant problems, the CMA's chief executive Andrea Coscelli said today.Merging companies that put forward complicated remedies to address the UK competition regulator’s concerns about their deals are unlikely to get very far, its chief executive said today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login